Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Viridian Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- +8 vs. Q3 2023
- Shares held
- 60.1M
- +9.99M (+19.9%) vs. Q3 2023
- Total value
- $1.31B
- +$540.0M (+70.1%) vs. Q3 2023
- New holders
- 25
- 49 more added
- Sold out
- 17
- 43 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $2.50B |
| Q1 2026 | 225 | $2.21B |
| Q4 2025 | 229 | $3.36B |
| Q3 2025 | 169 | $2.01B |
| Q2 2025 | 171 | $1.32B |
| Q1 2025 | 177 | $1.23B |
| Q4 2024 | 179 | $1.75B |
| Q3 2024 | 165 | $1.98B |
| Q2 2024 | 138 | $906.2M |
| Q1 2024 | 136 | $1.24B |
| Q4 2023 | 132 | $1.31B |
| Q3 2023 | 124 | $769.9M |
| Q2 2023 | 128 | $1.12B |
| Q1 2023 | 135 | $1.10B |
| Q4 2022 | 122 | $1.21B |
| Q3 2022 | 105 | $778.5M |
| Q2 2022 | 84 | $327.7M |
| Q1 2022 | 72 | $460.9M |
| Q4 2021 | 55 | $459.8M |
| Q3 2021 | 39 | $223.7M |
| Q2 2021 | 26 | $109.8M |
| Q1 2021 | 33 | $84.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 360,332 | $7.85M | 6.57% | +360,332 | New |
| Charles Schwab Investment Management Inc | 371,311 | $8.09M | 0.00% | +58,094+18.5% | Added |
| Goldman Sachs Group Inc | 381,737 | $8.31M | 0.00% | −17,543−4.4% | Reduced |
| Northern Trust Corp | 413,641 | $9.01M | 0.00% | +11,975+3.0% | Added |
| Eagle Asset Management Inc | 453,308 | $9.87M | 0.05% | −5,861−1.3% | Reduced |
| Morgan Stanley | 524,901 | $11.4M | 0.00% | +191,178+57.3% | Added |
| Jefferies Financial Group Inc. | 540,669 | $11.8M | 0.18% | +540,669 | New |
| 5AM Venture Management, LLC | 586,595 | $12.8M | 3.39% | +176,595+43.1% | Added |
| Logos Global Management LP | 600,000 | $13.1M | 1.45% | −450,000−42.9% | Reduced |
| RTW Investments, LP | 605,816 | $13.2M | 0.21% | +605,816 | New |
| Kynam Capital Management, LP | 607,915 | $13.2M | 1.50% | −91,766−13.1% | Reduced |
| Octagon Capital Advisors LP | 620,000 | $13.5M | 2.16% | −447,143−41.9% | Reduced |
| Tang Capital Management LLC | 692,925 | $15.1M | 1.39% | +23,800+3.6% | Added |
| Citadel Advisors LLC | 886,641 | $19.3M | 0.02% | +784,210+765.6% | Added |
| Polar Capital Holdings Plc | 979,917 | $21.3M | 0.15% | −620,083−38.8% | Reduced |
| Geode Capital Management, LLC | 994,468 | $21.7M | 0.00% | +135,373+15.8% | Added |
| Vestal Point Capital, LP | 1,000,000 | $21.8M | 2.31% | +1,000,000 | New |
| Pictet Asset Management Holding SA | 1,050,876 | $22.9M | 0.03% | −15,467−1.5% | Reduced |
| Yiheng Capital Management, L.P. | 1,228,534 | $26.8M | 3.31% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 1,369,623 | $29.8M | 3.15% | 00.0% | Unchanged |
| Vivo Capital, LLC | 1,678,207 | $36.6M | 2.99% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,730,212 | $37.7M | 0.84% | +719,007+71.1% | Added |
| Commodore Capital LP | 1,924,074 | $41.9M | 3.66% | −275,926−12.5% | Reduced |
| Alliancebernstein L.P. | 2,059,464 | $44.9M | 0.02% | +168,466+8.9% | Added |
| Maverick Capital LtdSuperinvestorMaverick Capital | 2,325,841 | $50.7M | 1.04% | +2,325,841 | New |
| State Street Corp | 2,708,383 | $59.0M | 0.00% | −233,307−7.9% | Reduced |
| Vanguard Group Inc | 3,000,948 | $65.4M | 0.00% | +552,933+22.6% | Added |
| BlackRock Inc. | 3,426,450 | $74.6M | 0.00% | +433,387+14.5% | Added |
| Deep Track Capital, LP | 3,631,728 | $79.1M | 2.77% | +668,461+22.6% | Added |
| VR Adviser, LLC | 3,882,623 | $84.6M | 5.80% | +800,001+26.0% | Added |
| Paradigm Biocapital Advisors LP | 4,794,488 | $104.4M | 4.89% | +1,112,741+30.2% | Added |
| FMR LLC | 7,625,542 | $166.1M | 0.01% | +7,363,354+2,808.4% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −2,007,946−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −504,978−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −439,191−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −360,830−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −94,005−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −80,002−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −61,654−100.0% | Sold out |
| Chartwell Investment Partners, LLC | 0 | $0 | 0.00% | −39,600−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −23,857−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −17,223−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −16,495−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −10,844−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,519−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |